Susquehanna Fundamental Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$24.5M	Buy	23,286 +22,006	+1,719%	+$21.3M	0.56%	39
2024 Q1	$1.23M	Buy	+1,280	New	+$1.22M	0.06%	313
2023 Q4	–	Sell	-5,488	Closed	-$4.52M	–	270
2023 Q3	$4.52M	Sell	5,488 -8,523	-61%	-$6.7M	0.29%	94
2023 Q2	$10.1M	Hold	14,011	–	–	0.37%	78
2023 Q1	$11.5M	Sell	14,011 -6,159	-31%	-$4.65M	0.27%	109
2022 Q4	$14.6M	Sell	20,170 -1,245	-6%	-$919K	0.25%	117
2022 Q3	$14.8M	Buy	+21,415	New	+$13.5M	0.25%	97
2022 Q1	–	Sell	-5,059	Closed	-$3.19M	–	1668
2021 Q4	$3.19M	Sell	5,059 -2,483	-33%	-$1.53M	0.08%	302
2021 Q3	$4.56M	Buy	7,542 +2,747	+57%	+$1.71M	0.08%	318
2021 Q2	$2.68M	Sell	4,795 -20,708	-81%	-$10.5M	0.05%	504
2021 Q1	$12.1M	Buy	25,503 +13,833	+119%	+$6.73M	0.21%	120
2020 Q4	$5.64M	Buy	11,670 +9,970	+586%	+$5.38M	0.1%	279
2020 Q3	$952K	Buy	+1,700	New	+$1.03M	0.03%	659